Pharmacogenetics of CYP3A5 on Carbamazepine pharmacokinetics in epileptic patients developing toxicity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2164
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pharmacogenetics of CYP3A5 on Carbamazepine pharmacokinetics in epileptic patients developing toxicity ; volume:15 ; number:2 ; day:2 ; month:4 ; year:2014 ; pages:1 ; date:4.2014
BMC genomics ; 15, Heft 2 (2.4.2014), 1, 4.2014
- Urheber
-
Al-Gahtany, Mubarak
- Beteiligte Personen und Organisationen
-
Karunakaran, Gauthaman
Munisamy, Murali
SpringerLink (Online service)
- DOI
-
10.1186/1471-2164-15-S2-P2
- URN
-
urn:nbn:de:1111-201607299126
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Al-Gahtany, Mubarak
- Karunakaran, Gauthaman
- Munisamy, Murali
- SpringerLink (Online service)
Ähnliche Objekte (12)
Everolimus pharmacokinetics and its exposure–toxicity relationship in patients with thyroid cancer
Pharmacokinetics, toxicity, and cytochrome P450 modulatory activity of plumbagin
Pharmacokinetics and toxicity evaluation following oral exposure to bisphenol F
Serum and urine ghrelin in adult epileptic patients
SOP: First-ever epileptic seizure in adult patients
Prevention and management of anticancer drug toxicity : the significance of clinical pharmacokinetics
Propofol toxicity in the developing mouse heart mitochondria
Epilepsy and quality of life in Iranian epileptic patients
Pharmacokinetics of antibiotics in elderly patients
Acute Toxicity, Biodistribution, and Pharmacokinetics Studies of Pegylated Platinum Nanoparticles in Mouse Model
Pharmacokinetics, radiation dosimetry, acute toxicity and automated synthesis of [18F]AmBF3-TATE
Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration
Everolimus pharmacokinetics and its exposure–toxicity relationship in patients with thyroid cancer
Pharmacokinetics, toxicity, and cytochrome P450 modulatory activity of plumbagin
Pharmacokinetics and toxicity evaluation following oral exposure to bisphenol F
Serum and urine ghrelin in adult epileptic patients
SOP: First-ever epileptic seizure in adult patients
Prevention and management of anticancer drug toxicity : the significance of clinical pharmacokinetics
Propofol toxicity in the developing mouse heart mitochondria
Epilepsy and quality of life in Iranian epileptic patients
Pharmacokinetics of antibiotics in elderly patients
Acute Toxicity, Biodistribution, and Pharmacokinetics Studies of Pegylated Platinum Nanoparticles in Mouse Model
Pharmacokinetics, radiation dosimetry, acute toxicity and automated synthesis of [18F]AmBF3-TATE
Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration
Everolimus pharmacokinetics and its exposure–toxicity relationship in patients with thyroid cancer
Pharmacokinetics, toxicity, and cytochrome P450 modulatory activity of plumbagin
Pharmacokinetics and toxicity evaluation following oral exposure to bisphenol F
Serum and urine ghrelin in adult epileptic patients
SOP: First-ever epileptic seizure in adult patients
Prevention and management of anticancer drug toxicity : the significance of clinical pharmacokinetics
Propofol toxicity in the developing mouse heart mitochondria
Epilepsy and quality of life in Iranian epileptic patients
Pharmacokinetics of antibiotics in elderly patients
Acute Toxicity, Biodistribution, and Pharmacokinetics Studies of Pegylated Platinum Nanoparticles in Mouse Model
Pharmacokinetics, radiation dosimetry, acute toxicity and automated synthesis of [18F]AmBF3-TATE